Murphy James R

Chairman and CEO, DirectorBENTLEY PHARMACEUTICALS INC (BNT) · full profile →Form 4 · filed Jul 24, 2008
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
23
3 non-derivative · 20 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 22, 2008Disposed to issuer(D)429K$14.82$6.4M0
Jul 22, 2008Disposed to issuer(D)12K$14.82$179K0
Jul 22, 2008Disposed to issuer(D)100$14.82$1K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 22, 2008Disposed to issuer(D)67K0
Jul 22, 2008Disposed to issuer(D)27K0
Jul 22, 2008Disposed to issuer(D)46K0
Jul 22, 2008Disposed to issuer(D)46K0
Jul 22, 2008Disposed to issuer(D)46K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)25K0
Jul 22, 2008Disposed to issuer(D)25K0
Jul 22, 2008Disposed to issuer(D)25K0
Jul 22, 2008Disposed to issuer(D)25K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)33K0
Jul 22, 2008Disposed to issuer(D)75K0
Jul 22, 2008Disposed to issuer(D)50K0
Jul 22, 2008Disposed to issuer(D)58K0
Jul 22, 2008Disposed to issuer(D)17K0

Transaction Codes

D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-08-043646) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.